Skip to main content
Erschienen in: Wiener klinische Wochenschrift 3-4/2017

06.09.2016 | original article

Seroepidemiology of cytomegalovirus infections in Croatia

verfasst von: Tatjana Vilibic-Cavlek, MD, PhD, Branko Kolaric, Natasa Beader, Izabela Vrtar, Irena Tabain, Gordana Mlinaric-Galinovic

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 3-4/2017

Einloggen, um Zugang zu erhalten

Summary

Background

Cytomegalovirus (CMV) is endemic worldwide, with marked differences in the seroprevalence rates between countries. The aim of this study was to analyze the seroprevalence of CMV infections in Croatia.

Methods

During a 3-year period (2013–2015) 2438 consecutive serum samples collected from Croatian residents were tested for the presence of CMV IgM and IgG antibodies using enzyme-linked immunoassay. The IgM/IgG positive samples were further tested for IgG avidity.

Results

The overall seroprevalence rates for CMV IgG and IgM antibodies were 74.4 % and 4.3 %, respectively. The IgG seroprevalence showed significant differences between population groups: children/adolescents 54.6 %, general adult population 77.2 %, hemodialysis patients 91.4 % (p < 0.001). Seropositivity of CMV was strongly age-dependent with prevalences ranging from 53.0 % in children less than 10 years old to 93.8 % in persons above 60 years (p < 0.001). There was no difference in the prevalence rate between women with normal pregnancy and women with poor obstetric history. Gender and place of residence were not associated with CMV seropositivity. Using IgG avidity, current/recent primary CMV infection was confirmed by a low/borderline avidity index (AI) in 46.7 % participants, while in 53.3 % a high AI indicated CMV reactivation or reinfection. Primary infections were detected mainly in children and adolescents (83.2 % and 70.5 %, respectively), while reactivation/reinfection was common in persons older than 40 (77.0–100 %). Reactivation/reinfection was most commonly detected in hemodialysis patients (92.3 %). Logistic regression showed that older age and being on hemodialysis were significant predictors of CMV seropositivity.

Conclusion

Infections with CMV are widespread in the Croatian population. Older age and being on hemodialysis appear to be the main risk factors for CMV infection.
Literatur
1.
Zurück zum Zitat Adjei AA, Armah HB, Gbagbo F, Boamah I, Adu-Gyamfi C, Asare I. Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa. BMC Infect Dis. 2008;8:111.CrossRefPubMedPubMedCentral Adjei AA, Armah HB, Gbagbo F, Boamah I, Adu-Gyamfi C, Asare I. Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa. BMC Infect Dis. 2008;8:111.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20:202–13.CrossRefPubMed Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20:202–13.CrossRefPubMed
3.
Zurück zum Zitat Hodinka RL. Human cytomegalovirus. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnick DW, editors. Manual of clinical microbiology, 10th edn. Washington, DC: ASM Press; 2011. pp. 1558–74.CrossRef Hodinka RL. Human cytomegalovirus. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnick DW, editors. Manual of clinical microbiology, 10th edn. Washington, DC: ASM Press; 2011. pp. 1558–74.CrossRef
4.
Zurück zum Zitat Lancini D, Faddy HM, Flower R, Hogan C. Cytomegalovirus disease in immunocompetent adults. Med J Aust. 2014;201:578–80.PubMed Lancini D, Faddy HM, Flower R, Hogan C. Cytomegalovirus disease in immunocompetent adults. Med J Aust. 2014;201:578–80.PubMed
5.
Zurück zum Zitat Karakozis S, Gongora E, Caceres M, Brun E, Cook JW. Life-threatening cytomegalovirus colitis in the immunocompetent patient: report of a case and review of the literature. Dis Colon Rectum. 2001;44:1716–20.CrossRefPubMed Karakozis S, Gongora E, Caceres M, Brun E, Cook JW. Life-threatening cytomegalovirus colitis in the immunocompetent patient: report of a case and review of the literature. Dis Colon Rectum. 2001;44:1716–20.CrossRefPubMed
6.
Zurück zum Zitat Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008;5:47.CrossRefPubMedPubMedCentral Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008;5:47.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Orasch C, Conen A. Severe primary cytomegalovirus infection in the immunocompetent adult patient: a case series. Scand J Infect Dis. 2012;44:987–91.CrossRefPubMed Orasch C, Conen A. Severe primary cytomegalovirus infection in the immunocompetent adult patient: a case series. Scand J Infect Dis. 2012;44:987–91.CrossRefPubMed
8.
Zurück zum Zitat Cavdar C, Celtik A, Saglam F, et al. Cytomegalovirus disease in renal transplant recipients: a single-center experience. Ren Fail. 2008;30:503–6.CrossRefPubMed Cavdar C, Celtik A, Saglam F, et al. Cytomegalovirus disease in renal transplant recipients: a single-center experience. Ren Fail. 2008;30:503–6.CrossRefPubMed
9.
Zurück zum Zitat Beader N, Kalenić S, Labar B. Diagnostic approach and therapy for cytomegalovirus (CMV) infection following allogeneic stem cell transplantation. Lijec Vjesn. 2011;133:389–96.PubMed Beader N, Kalenić S, Labar B. Diagnostic approach and therapy for cytomegalovirus (CMV) infection following allogeneic stem cell transplantation. Lijec Vjesn. 2011;133:389–96.PubMed
10.
Zurück zum Zitat Varga M, Görög D, Kári D, et al. Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group. Transplant Proc. 2011;43:1233–5.CrossRefPubMed Varga M, Görög D, Kári D, et al. Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group. Transplant Proc. 2011;43:1233–5.CrossRefPubMed
11.
Zurück zum Zitat Wang C, Zhang X, Bialek S, Cannon MJ. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis. 2011;52:e11–e13.CrossRefPubMed Wang C, Zhang X, Bialek S, Cannon MJ. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis. 2011;52:e11–e13.CrossRefPubMed
12.
Zurück zum Zitat Aarnisalo J, Ilonen J, Vainionpää R, Volanen I, Kaitosaari T, Simell O. Development of antibodies against cytomegalovirus, varicella-zoster virus and herpes simplex virus in Finland during the first eight years of life: a prospective study. Scand J Infect Dis. 2003;35:750–3.CrossRefPubMed Aarnisalo J, Ilonen J, Vainionpää R, Volanen I, Kaitosaari T, Simell O. Development of antibodies against cytomegalovirus, varicella-zoster virus and herpes simplex virus in Finland during the first eight years of life: a prospective study. Scand J Infect Dis. 2003;35:750–3.CrossRefPubMed
13.
Zurück zum Zitat Ataman S, Colak D, Günseren F, et al. Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey. Mikrobiyol Bul. 2007;41:545–55.PubMed Ataman S, Colak D, Günseren F, et al. Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey. Mikrobiyol Bul. 2007;41:545–55.PubMed
14.
Zurück zum Zitat Lopo S, Vinagre E, Palminha P, Paixao MT, Nogueira P, Freitas MG. Seroprevalence to cytomegalovirus in the Portuguese population, 2002–2003. Euro Surveill. 2011;16(25):pii: 19896. Lopo S, Vinagre E, Palminha P, Paixao MT, Nogueira P, Freitas MG. Seroprevalence to cytomegalovirus in the Portuguese population, 2002–2003. Euro Surveill. 2011;16(25):pii: 19896.
15.
Zurück zum Zitat Zebrun AB, Kuliasheva LB, Ermolenko KD, Zakrevskaia AV. Spread of herpesvirus infections in children and adults in St. Petersburg according to seroepidemiologic study data. Zh Mikrobiol Epidemiol Immunobiol. 2013;6:30–6. Zebrun AB, Kuliasheva LB, Ermolenko KD, Zakrevskaia AV. Spread of herpesvirus infections in children and adults in St. Petersburg according to seroepidemiologic study data. Zh Mikrobiol Epidemiol Immunobiol. 2013;6:30–6.
16.
Zurück zum Zitat Dolgikh TI, Dalmatov VV, Zaparii NS, Kadtsyna TV. Cytomegalovirus infection in Omsk region. Zh Mikrobiol Epidemiol Immunobiol. 2008;3:85–7. Dolgikh TI, Dalmatov VV, Zaparii NS, Kadtsyna TV. Cytomegalovirus infection in Omsk region. Zh Mikrobiol Epidemiol Immunobiol. 2008;3:85–7.
17.
Zurück zum Zitat Lübeck PR, Doerr HW, Rabenau HF. Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed? Med Microbiol Immunol. 2010;199:53–60.CrossRefPubMed Lübeck PR, Doerr HW, Rabenau HF. Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed? Med Microbiol Immunol. 2010;199:53–60.CrossRefPubMed
18.
Zurück zum Zitat Lepage N, Leroyer A, Cherot-Kornobis N, Lartigau I, Miczek S, Sobaszek A. Cytomegalovirus seroprevalence in exposed and unexposed populations of hospital employees. Eur J Clin Microbiol Infect Dis. 2011;30:65–70.CrossRefPubMed Lepage N, Leroyer A, Cherot-Kornobis N, Lartigau I, Miczek S, Sobaszek A. Cytomegalovirus seroprevalence in exposed and unexposed populations of hospital employees. Eur J Clin Microbiol Infect Dis. 2011;30:65–70.CrossRefPubMed
19.
Zurück zum Zitat Korndewal MJ, Mollema L, Tcherniaeva I, et al. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications. J Clin Virol. 2015;63:53–8.CrossRefPubMed Korndewal MJ, Mollema L, Tcherniaeva I, et al. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications. J Clin Virol. 2015;63:53–8.CrossRefPubMed
20.
Zurück zum Zitat Odland JØ, Sergejeva IV, Ivaneev MD, Jensen IP, Stray-Pedersen B. Seropositivity of cytomegalovirus, parvovirus and rubella in pregnant women and recurrent aborters in Leningrad County, Russia. Acta Obstet Gynecol Scand. 2001;80:1025–9.CrossRefPubMed Odland JØ, Sergejeva IV, Ivaneev MD, Jensen IP, Stray-Pedersen B. Seropositivity of cytomegalovirus, parvovirus and rubella in pregnant women and recurrent aborters in Leningrad County, Russia. Acta Obstet Gynecol Scand. 2001;80:1025–9.CrossRefPubMed
21.
Zurück zum Zitat Leuridan E, Ieven M, Hens N, Damme P van. High susceptibility to cytomegalovirus infection of pregnant women in Flanders, Belgium. Facts Views Vis Obgyn. 2012;4:76–81.PubMedPubMedCentral Leuridan E, Ieven M, Hens N, Damme P van. High susceptibility to cytomegalovirus infection of pregnant women in Flanders, Belgium. Facts Views Vis Obgyn. 2012;4:76–81.PubMedPubMedCentral
22.
Zurück zum Zitat N’Diaye DS, Yazdanpanah Y, Krivine A, et al. Predictive factors of cytomegalovirus seropositivity among pregnant women in Paris, France. PLOS ONE. 2014;9(2):e89857.CrossRefPubMedPubMedCentral N’Diaye DS, Yazdanpanah Y, Krivine A, et al. Predictive factors of cytomegalovirus seropositivity among pregnant women in Paris, France. PLOS ONE. 2014;9(2):e89857.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Odland ML, Strand KM, Nordbø SA, Forsmo S, Austgulen R, Iversen AC. Changing patterns of cytomegalovirus seroprevalence among pregnant women in Norway between 1995 and 2009 examined in the Norwegian Mother and Child Cohort Study and two cohorts from Sor-Trondelag County: a cross-sectional study. BMJ Open. 2013;3(9):e003066.CrossRefPubMedPubMedCentral Odland ML, Strand KM, Nordbø SA, Forsmo S, Austgulen R, Iversen AC. Changing patterns of cytomegalovirus seroprevalence among pregnant women in Norway between 1995 and 2009 examined in the Norwegian Mother and Child Cohort Study and two cohorts from Sor-Trondelag County: a cross-sectional study. BMJ Open. 2013;3(9):e003066.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Aynioglu A, Aynioglu O, Altunok ES. Seroprevalence of toxoplasma gondii, rubella and cytomegalovirus among pregnant females in north-western Turkey. Acta Clin Belg. 2015; doi:10.1179/2295333715Y.0000000021. Aynioglu A, Aynioglu O, Altunok ES. Seroprevalence of toxoplasma gondii, rubella and cytomegalovirus among pregnant females in north-western Turkey. Acta Clin Belg. 2015; doi:10.​1179/​2295333715Y.​0000000021.
25.
Zurück zum Zitat Trkulic M, Jovanovic D, Ostojic G, Kovacevic Z, Taseski J. Cytomegalovirus infection in patients with kidney diseases. Vojnosanit Pregl. 2000;57:63–7.PubMed Trkulic M, Jovanovic D, Ostojic G, Kovacevic Z, Taseski J. Cytomegalovirus infection in patients with kidney diseases. Vojnosanit Pregl. 2000;57:63–7.PubMed
26.
Zurück zum Zitat Ocak S, Duran N, Eskiocak AF. Seroprevalence of cytomegalovirus antibodies in hemodialysis patients. Turk J Med Sci. 2006;36:155–8. Ocak S, Duran N, Eskiocak AF. Seroprevalence of cytomegalovirus antibodies in hemodialysis patients. Turk J Med Sci. 2006;36:155–8.
27.
Zurück zum Zitat Betjes MG, Litjens NH, Zietse R. Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease. Nephrol Dial Transplant. 2007;22:3298–303.CrossRefPubMed Betjes MG, Litjens NH, Zietse R. Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease. Nephrol Dial Transplant. 2007;22:3298–303.CrossRefPubMed
28.
Zurück zum Zitat Vilibic-Cavlek T, Ljubin-Sternak S, Ban M, Kolaric B, Sviben M, Mlinaric-Galinovic G. Seroprevalence of TORCH infections in women of childbearing age in Croatia. J Matern Fet Neonatal Med. 2011;24:280–3.CrossRef Vilibic-Cavlek T, Ljubin-Sternak S, Ban M, Kolaric B, Sviben M, Mlinaric-Galinovic G. Seroprevalence of TORCH infections in women of childbearing age in Croatia. J Matern Fet Neonatal Med. 2011;24:280–3.CrossRef
29.
Zurück zum Zitat Vilibic-Cavlek T, Kolaric B, Ljubin-Sternak S, Kos M, Kaic B, Mlinaric-Galinovic G. Prevalence and dynamics of cytomegalovirus infection among patients undergoing chronic hemodialysis. Indian J Nephrol. 2015;25:95–8.CrossRefPubMedPubMedCentral Vilibic-Cavlek T, Kolaric B, Ljubin-Sternak S, Kos M, Kaic B, Mlinaric-Galinovic G. Prevalence and dynamics of cytomegalovirus infection among patients undergoing chronic hemodialysis. Indian J Nephrol. 2015;25:95–8.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Ory Manchón F de, Sanz Moreno JC, Castañeda López R, Ramírez Fernández R, León Rega P, Pachón del Amo I. Cytomegalovirus seroepidemiology in the community of Madrid. Rev Esp Salud Publica. 2001;75:55–62.CrossRefPubMed Ory Manchón F de, Sanz Moreno JC, Castañeda López R, Ramírez Fernández R, León Rega P, Pachón del Amo I. Cytomegalovirus seroepidemiology in the community of Madrid. Rev Esp Salud Publica. 2001;75:55–62.CrossRefPubMed
31.
Zurück zum Zitat Francisse S, Revelard P, de Maertelaer V, Strebelle E, Englert Y, Liesnard C. Human cytomegalovirus seroprevalence and risk of seroconversion in a fertility clinic population. Obstet Gynecol. 2009;114:285–91.CrossRefPubMed Francisse S, Revelard P, de Maertelaer V, Strebelle E, Englert Y, Liesnard C. Human cytomegalovirus seroprevalence and risk of seroconversion in a fertility clinic population. Obstet Gynecol. 2009;114:285–91.CrossRefPubMed
32.
Zurück zum Zitat Enders G, Daiminger A, Lindemann L, et al. Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996–2010. Med Microbiol Immunol. 2012;201:303–9.CrossRefPubMed Enders G, Daiminger A, Lindemann L, et al. Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996–2010. Med Microbiol Immunol. 2012;201:303–9.CrossRefPubMed
33.
Zurück zum Zitat Rijckevorsel GG van, Bovée LP, Damen M, Sonder GJ, Schim van der Loeff MF, Hoek A van den. Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care. BMC Public Health. 2012;12:475.CrossRefPubMedPubMedCentral Rijckevorsel GG van, Bovée LP, Damen M, Sonder GJ, Schim van der Loeff MF, Hoek A van den. Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care. BMC Public Health. 2012;12:475.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Sibrowski W, Kühnl P, Kalmar G, Albert S, Böhm BO, Doerr HW. Cytomegalovirus diagnosis in blood donors and risk patients. Beitr Infusionsther. 1990;26:37–9.PubMed Sibrowski W, Kühnl P, Kalmar G, Albert S, Böhm BO, Doerr HW. Cytomegalovirus diagnosis in blood donors and risk patients. Beitr Infusionsther. 1990;26:37–9.PubMed
35.
Zurück zum Zitat Pembrey L, Raynor P, Griffiths P, Chaytor S, Wright J, Hall AJ. Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study. PLOS ONE. 2013;8(11):e81881.CrossRefPubMedPubMedCentral Pembrey L, Raynor P, Griffiths P, Chaytor S, Wright J, Hall AJ. Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study. PLOS ONE. 2013;8(11):e81881.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Alanen A, Kahala K, Vahlberg T, Koskela P, Vainionpää R. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus,cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG. 2005;112:50–6.CrossRefPubMed Alanen A, Kahala K, Vahlberg T, Koskela P, Vainionpää R. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus,cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG. 2005;112:50–6.CrossRefPubMed
37.
Zurück zum Zitat Wujcicka W, Gaj Z, Wilczyński J, Sobala W, Spiewak E, Nowakowska D. Impact of socioeconomic risk factors on the seroprevalence of cytomegalovirus infections in a cohort of pregnant Polish women between 2010 and 2011. Eur J Clin Microbiol Infect Dis. 2014;33:1951–8.CrossRefPubMedPubMedCentral Wujcicka W, Gaj Z, Wilczyński J, Sobala W, Spiewak E, Nowakowska D. Impact of socioeconomic risk factors on the seroprevalence of cytomegalovirus infections in a cohort of pregnant Polish women between 2010 and 2011. Eur J Clin Microbiol Infect Dis. 2014;33:1951–8.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Uyar Y, Balci A, Akcali A, Cabar C. Prevalence of rubella and cytomegalovirus antibodies among pregnant women in Northern Turkey. New Microbiol. 2008;31:451–5.PubMed Uyar Y, Balci A, Akcali A, Cabar C. Prevalence of rubella and cytomegalovirus antibodies among pregnant women in Northern Turkey. New Microbiol. 2008;31:451–5.PubMed
39.
Zurück zum Zitat Barlinn R, Vainio K, Samdal HH, Nordbø SA, Nøkleby H, Dudman SG. Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women. J Med Virol. 2014;86:820–6.CrossRefPubMed Barlinn R, Vainio K, Samdal HH, Nordbø SA, Nøkleby H, Dudman SG. Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women. J Med Virol. 2014;86:820–6.CrossRefPubMed
40.
Zurück zum Zitat Knowles SJ, Grundy K, Cahill I, Cafferkey MT, Geary M. Low cytomegalovirus sero-prevalence in Irish pregnant women. Ir Med J. 2005;98:210–2.PubMed Knowles SJ, Grundy K, Cahill I, Cafferkey MT, Geary M. Low cytomegalovirus sero-prevalence in Irish pregnant women. Ir Med J. 2005;98:210–2.PubMed
Metadaten
Titel
Seroepidemiology of cytomegalovirus infections in Croatia
verfasst von
Tatjana Vilibic-Cavlek, MD, PhD
Branko Kolaric
Natasa Beader
Izabela Vrtar
Irena Tabain
Gordana Mlinaric-Galinovic
Publikationsdatum
06.09.2016
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 3-4/2017
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-016-1069-7

Weitere Artikel der Ausgabe 3-4/2017

Wiener klinische Wochenschrift 3-4/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.